During the past decade, Conklin Regional Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Conklin Regional Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator and "Eastern Cooperative Oncology Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Conklin Regional Cancer Center" are "Adenocarcinoma of the Colon" (1 trials), "Breast Cancer" (1 trials), "Kidney Cancer" (1 trials) and "Stage III Colon Cancer" (1 trials). Many other conditions were trialed in "Conklin Regional Cancer Center" in a lesser frequency.

Most popular intervention types in "Conklin Regional Cancer Center" are "Drug" (3 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (1 trials), "Docetaxel" (1 trials), "Doxorubicin" (1 trials), "Locally Directed Therapy" (1 trials) and "Paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Conklin Regional Cancer Center" are 2 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Conklin Regional Cancer Center". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Conklin Regional Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Conklin Regional Cancer Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".